Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...

A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...

Dr. Stephen Hauser was a young resident at Harvard when he met his first patient with multiple sclerosis, a woman with a thriving professional life who’d been completely wiped out by her condition, ...

Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. For years prior, she’d had severe fatigue, which a neurologist initially suspected was caused by ...

JT Lew, PharmD, MBA, managed care pharmacist at MultiCare Health System, spoke to the impacts of processes such as prior authorization and step therapy requirements in the realm of multiple sclerosis ...

Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...

STOCKHOLM ― Until their mid to late 30s, some people with multiple sclerosis (MS) can better compensate for damage to their central nervous system, new evidence suggests. Thereafter, at about age 40, ...

This is Jayne Charles's third fundraiser for the Wolverhampton MS Therapy Centre.

A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...